Australian Clinical Labs Ltd (ACL) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.416x

Based on the latest financial reports, Australian Clinical Labs Ltd (ACL) has a cash flow conversion efficiency ratio of 0.416x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$62.87 Million ≈ $44.48 Million USD) by net assets (AU$151.04 Million ≈ $106.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Australian Clinical Labs Ltd for the company's overall valuation and market capitalisation.

Australian Clinical Labs Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Australian Clinical Labs Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Australian Clinical Labs Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Australian Clinical Labs Ltd ranked by their cash flow conversion efficiency. Explore Australian Clinical Labs Ltd (ACL) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Civeo Corp NYSE:CVEO	0.076x
Energy Recovery Inc NASDAQ:ERII	0.095x
Magnetic Resources NL AU:MAUCA	-0.681x
Vetropack Holding SA SW:VETN	0.157x
Liaoning He Eye Hospital Group Co. LTD. SHE:301103	N/A
NHN KCP Corp KQ:060250	0.513x
POSCO M-TECH Co. Ltd KQ:009520	-0.006x
Avidia Bancorp, Inc. NYSE:AVBC	0.023x

Annual Cash Flow Conversion Efficiency for Australian Clinical Labs Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Australian Clinical Labs Ltd from 2016 to 2025. View ACL stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$171.98 Million ≈ $121.69 Million	AU$182.80 Million ≈ $129.34 Million	1.063x	0.00%
2024-12-31	AU$171.98 Million ≈ $121.69 Million	AU$182.80 Million ≈ $129.34 Million	1.063x	+18.39%
2024-06-30	AU$177.76 Million ≈ $125.78 Million	AU$159.59 Million ≈ $112.92 Million	0.898x	0.00%
2023-12-31	AU$177.76 Million ≈ $125.78 Million	AU$159.59 Million ≈ $112.92 Million	0.898x	+7.89%
2023-06-30	AU$172.67 Million ≈ $122.18 Million	AU$143.68 Million ≈ $101.66 Million	0.832x	0.00%
2022-12-31	AU$172.67 Million ≈ $122.18 Million	AU$143.68 Million ≈ $101.66 Million	0.832x	-31.88%
2022-06-30	AU$232.56 Million ≈ $164.55 Million	AU$284.09 Million ≈ $201.01 Million	1.222x	0.00%
2021-12-31	AU$232.56 Million ≈ $164.55 Million	AU$284.09 Million ≈ $201.01 Million	1.222x	-34.97%
2021-06-30	AU$81.91 Million ≈ $57.96 Million	AU$153.86 Million ≈ $108.87 Million	1.878x	0.00%
2020-12-31	AU$81.91 Million ≈ $57.96 Million	AU$153.86 Million ≈ $108.87 Million	1.878x	+27.37%
2020-06-30	AU$68.99 Million ≈ $48.81 Million	AU$101.74 Million ≈ $71.98 Million	1.475x	0.00%
2019-12-31	AU$68.99 Million ≈ $48.81 Million	AU$101.74 Million ≈ $71.98 Million	1.475x	+3536.33%
2019-06-30	AU$27.42 Million ≈ $19.40 Million	AU$1.11 Million ≈ $786.81K	0.041x	0.00%
2018-12-31	AU$27.42 Million ≈ $19.40 Million	AU$1.11 Million ≈ $786.81K	0.041x	-95.28%
2018-06-30	AU$5.46 Million ≈ $3.86 Million	AU$4.69 Million ≈ $3.32 Million	0.860x	0.00%
2017-12-31	AU$5.46 Million ≈ $3.86 Million	AU$4.69 Million ≈ $3.32 Million	0.860x	+163.80%
2017-06-30	AU$14.12 Million ≈ $9.99 Million	AU$4.60 Million ≈ $3.26 Million	0.326x	0.00%
2016-12-31	AU$14.12 Million ≈ $9.99 Million	AU$4.60 Million ≈ $3.26 Million	0.326x	--

About Australian Clinical Labs Ltd

AU:ACL Australia Diagnostics & Research

Market Cap

$374.47 Million

AU$529.24 Million AUD

Market Cap Rank

#14014 Global

#370 in Australia

Share Price

AU$2.82

Change (1 day)

+3.30%

52-Week Range

AU$1.84 - AU$2.99

All Time High

AU$5.09